Literature DB >> 16609806

Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases.

Luis Velázquez-Pérez1, Juan Fernandez-Ruiz, Rosalinda Díaz, Ruth Pérez González, Nalia Canales Ochoa, Gilberto Sánchez Cruz, Luis Enrique Almaguer Mederos, Edilberto Martínez Góngora, Robyn Hudson, René Drucker-Colin.   

Abstract

Olfactory function is affected in different neurodegenerative diseases. Recently, it has been found that some hereditary ataxias are also associated with significant olfactory impairment. However, the initial findings did not examine the nature of the olfactory impairment associated with these ataxias. In the present article the effect of spinocerebellar ataxia type 2 (SCA2) on olfactory function was studied in 53 SCA2 patients and 53 healthy control subjects from Holguín, Cuba. Several tests were applied to evaluate olfactory threshold, description, identification and discrimination. The results show significant impairment in SCA2 patients on all olfactory measurements, and the pattern of olfactory deficits found suggests that they have much in common with those reported for other neurodegenerative diseases such as Parkinson's and Alzheimer's diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16609806     DOI: 10.1007/s00415-006-0183-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

1.  Olfaction.

Authors:  R L Doty
Journal:  Annu Rev Psychol       Date:  2001       Impact factor: 24.137

2.  Effect of air pollution on olfactory function in residents of Mexico City.

Authors:  Robyn Hudson; Aline Arriola; Margarita Martínez-Gómez; Hans Distel
Journal:  Chem Senses       Date:  2005-12-14       Impact factor: 3.160

3.  Odorant-induced and sniff-induced activation in the cerebellum of the human.

Authors:  N Sobel; V Prabhakaran; C A Hartley; J E Desmond; Z Zhao; G H Glover; J D Gabrieli; E V Sullivan
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

4.  Olfactory impairments in patients with unilateral cerebellar lesions are selective to inputs from the contralesional nostril.

Authors:  Joel D Mainland; Bradley N Johnson; Rehan Khan; Richard B Ivry; Noam Sobel
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

5.  Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguín, Cuba.

Authors:  G Orozco Diaz; A Nodarse Fleites; R Cordovés Sagaz; G Auburger
Journal:  Neurology       Date:  1990-09       Impact factor: 9.910

6.  Functional mapping of human brain in olfactory processing: a PET study.

Authors:  A Qureshy; R Kawashima; M B Imran; M Sugiura; R Goto; K Okada; K Inoue; M Itoh; T Schormann; K Zilles; H Fukuda
Journal:  J Neurophysiol       Date:  2000-09       Impact factor: 2.714

7.  Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.

Authors:  D P Devanand; K S Michaels-Marston; X Liu; G H Pelton; M Padilla; K Marder; K Bell; Y Stern; R Mayeux
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

Review 8.  Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance.

Authors:  U Rüb; D Del Turco; K Del Tredici; R A I de Vos; E R Brunt; G Reifenberger; C Seifried; C Schultz; G Auburger; H Braak
Journal:  Brain       Date:  2003-07-07       Impact factor: 13.501

9.  Olfactory dysfunction in cerebellar ataxia and multiple system atrophy.

Authors:  Michael Abele; Alexander Riet; Thomas Hummel; Thomas Klockgether; Ullrich Wüllner
Journal:  J Neurol       Date:  2003-12       Impact factor: 4.849

10.  Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Authors:  R L Doty; D A Deems; S Stellar
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

View more
  15 in total

1.  Cognitive deficits in Machado-Joseph disease correlate with hypoperfusion of visual system areas.

Authors:  Pedro Braga-Neto; Lívia Almeida Dutra; José Luiz Pedroso; André C Felício; Helena Alessi; Ruth F Santos-Galduroz; Paulo Henrique F Bertolucci; Mário Luiz V Castiglioni; Rodrigo Affonseca Bressan; Griselda Esther Jara de Garrido; Orlando Graziani Povoas Barsottini; Andrea Jackowski
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

2.  [Olfactory dysfunction in neurodegenerative disorders].

Authors:  A Hähner; A Welge-Lüssen
Journal:  HNO       Date:  2010-07       Impact factor: 1.284

Review 3.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

Review 4.  A comprehensive review of spinocerebellar ataxia type 2 in Cuba.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Julio Cesar García-Rodríguez; Luis Enrique Almaguer-Mederos; Tania Cruz-Mariño; José Miguel Laffita-Mesa
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

5.  ETS1 regulates the expression of ATXN2.

Authors:  Daniel R Scoles; Lance T Pflieger; Khanh K Thai; Stephen T Hansen; Warunee Dansithong; Stefan-M Pulst
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

6.  Higher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremor.

Authors:  Elan D Louis; Eileen Rios; Kathryn M Pellegrino; Wendy Jiang; Pam Factor-Litvak; Wei Zheng
Journal:  Neurotoxicology       Date:  2008-03-18       Impact factor: 4.294

7.  Olfactory impairment in familial ataxias.

Authors:  Mariana Moscovich; Renato Puppi Munhoz; Helio A Teive; Salmo Raskin; Margarete de J Carvalho; Egberto R Barbosa; Ronald Ranvaud; Jilin Liu; Karen McFarland; Tetsuo Ashizawa; Andrew J Lees; Laura Silveira-Moriyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-07-11       Impact factor: 10.154

8.  Non-motor and Extracerebellar Features in Spinocerebellar Ataxia Type 2.

Authors:  José Luiz Pedroso; Pedro Braga-Neto; Marcio Luiz Escorcio-Bezerra; Agessandro Abrahão; Marcus Vinicius Cristino de Albuquerque; Flavio Moura Rezende Filho; Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Franklin Roberto Pereira Borges; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Orlando G P Barsottini
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

Review 9.  Beta-carboline alkaloids and essential tremor: exploring the environmental determinants of one of the most prevalent neurological diseases.

Authors:  Elan D Louis; Wei Zheng
Journal:  ScientificWorldJournal       Date:  2010-09-01

10.  Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers.

Authors:  Luis Velázquez-Perez; Rosalinda Díaz; Ruth Pérez-González; Nalia Canales; Roberto Rodríguez-Labrada; Jacquelín Medrano; Gilberto Sánchez; Luis Almaguer-Mederos; Cira Torres; Juan Fernandez-Ruiz
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.